a clinical stage company, which engages in the research and development of therapies for cancer patients
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RSPKX | 24.31 | 0.34 | +1.42% |
Victory RS Partners R | |||
FETKX | 29.41 | 0.20 | +0.68% |
Fidelity Equity Dividend Income K | |||
GEMWX | 12.43 | N/A | N/A |
Goldman Sachs Emerging Mkt Eq ex. Chn R6 | |||
GTDIX | 32.27 | -0.14 | -0.43% |
Invesco EQV Emerging Markets All Cap R5 | |||
IGREX | 8.69 | -0.10 | -1.14% |
Invesco Global Real Estate R5 |
A.I.dvisor indicates that over the last year, ALXO has been loosely correlated with MDGL. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALXO jumps, then MDGL could also see price increases.
Ticker / NAME | Correlation To ALXO | 1D Price Change % | ||
---|---|---|---|---|
ALXO | 100% | -2.09% | ||
MDGL - ALXO | 56% Loosely correlated | +0.47% | ||
AXON - ALXO | 45% Loosely correlated | -0.73% | ||
AMRN - ALXO | 43% Loosely correlated | +0.87% | ||
ALNY - ALXO | 39% Loosely correlated | +0.60% | ||
AKRO - ALXO | 39% Loosely correlated | +5.59% | ||
More |